Shaobin Ni

Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy

The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update

A view on drug resistance in cancer

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future

Macrophages in immunoregulation and therapeutics

Targeting tumor-associated macrophages to synergize tumor immunotherapy

Inflammation and tumor progression: signaling pathways and targeted intervention

Incidence, Prevention, and Management of Complications Following Percutaneous Nephrolitholapaxy

Exit strategies following percutaneous nephrolithotomy (PCNL): a comparison of surgical outcomes in the Clinical Research Office of the Endourological Society (CROES) PCNL Global Study

EAU Guidelines on Interventional Treatment for Urolithiasis

Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic

The PI3K Pathway in Human Disease

Clonal status of actionable driver events and the timing of mutational processes in cancer evolution

Tubeless Percutaneous Nephrolithotomy is Associated With Less Pain and Shorter Hospitalization Compared with Standard or Small Bore Drainage: A Meta-analysis of Randomized, Controlled Trials

Bladder cancer cells induce immunosuppression of T cells by supporting PD‐L1 expression in tumour macrophages partially through interleukin 10

2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2

Laparoscopic Versus Open Nephroureterectomy for the Treatment of Upper Urinary Tract Urothelial Carcinoma: A Systematic Review and Cumulative Analysis of Comparative Studies

Down expression of LRP1B promotes cell migration via RhoA/Cdc42 pathway and actin cytoskeleton remodeling in renal cell cancer